Human health relies on the composition of microbiota in an individual’s gut and the synthesized metabolites that may alter the gut environment. Gut microbiota and faecal metabolites are involved in several gastrointestinal diseases. In this study, 16S rRNA-specific denaturing gradient gel electrophoresis and quantitative PCR analysis showed that the mean similarity of total bacteria was significantly different (P<0.001) in faecal samples from patients with irritable bowel syndrome (IBS; n = 11) and from non-IBS (nIBS) patients (n = 8). IBS subjects had a significantly higher diversity of total bacteria, as measured by the Shannon index (H′) (3.36<H′<4.37, P = 0.004), Bacteroidetes and lactobacilli; however, less diversity was observed for Bifidobacter (1.7< H′<3.08, P<0.05) and Clostridium coccoides (0.9< H′<2.98, P = 0.007). In this study, no significant difference was found in total bacterial quantity (P>0.05). GC/MS-based multivariate analysis delineated the faecal metabolites of IBS from nIBS samples. Elevated levels of amino acids (alanine and pyroglutamic acid) and phenolic compounds (hydroxyphenyl acetate and hydroxyphenyl propionate) were found in IBS. These results were highly correlated with the abundance of lactobacilli and Clostridium, which indicates an altered metabolism rate associated with these gut micro-organisms. A higher diversity of Bacteroidetes and Lactobacillus groups in IBS faecal samples also correlated with the respective total quantity. In addition, these changes altered protein and carbohydrate energy metabolism in the gut.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
ApajalahtiJ. H.,
SärkilahtiL. K.,
MäkiB. R.,
HeikkinenJ. P.,
NurminenP. H.,
HolbenW. E.1998; Effective recovery of bacterial DNA and percent-guanine-plus-cytosine-based analysis of community structure in the gastrointestinal tract of broiler chickens. Appl Environ Microbiol 64:4084–4088[PubMed]
BennoY.,
EndoK.,
MizutaniT.,
NambaY.,
KomoriT.,
MitsuokaT.1989; Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl Environ Microbiol 55:1100–1105[PubMed]
EngbergR. M.,
HedemannM. S.,
LeserT. D.,
JensenB. B.2000; Effect of zinc bacitracin and salinomycin on intestinal microflora and performance of broilers. Poult Sci 79:1311–1319[PubMed][CrossRef]
GaoX.,
Pujos-GuillotE.,
MartinJ. F.,
GalanP.,
JusteC.,
JiaW.,
SebedioJ. L.2009; Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. Anal Biochem 393:163–175 [View Article][PubMed]
HanS. H.,
LeeO. Y.,
BaeS. C.,
LeeS. H.,
ChangY. K.,
YangS. Y.,
YoonB. C.,
ChoiH. S.,
HahmJ. S. et al.2006; Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria. J Gastroenterol Hepatol 21:1687–1692 [View Article][PubMed]
HeaveyP. M.,
RowlandI. R.1999; The gut microflora of the developing infant: microbiology and metabolism. Microb Ecol Health Dis 11:75–83 [View Article]
Lara-VillosladaF.,
De HaroO.,
CamuescoD.,
ComaladaM.,
VelascoJ.,
ZarzueloA.,
XausJ.,
GalvezJ.2006; Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis. Eur J Nutr 45:418–425 [View Article][PubMed]
LiM.,
WangB.,
ZhangM.,
RantalainenM.,
WangS.,
ZhouH.,
ZhangY.,
ShenJ.,
PangX. et al.2008; Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A 105:2117–2122 [View Article][PubMed]
MatsukiT.,
WatanabeK.,
FujimotoJ.,
MiyamotoY.,
TakadaT.,
MatsumotoK.,
OyaizuH.,
TanakaR.2002; Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 68:5445–5451 [View Article][PubMed]
MortensenP. B.,
AndersenJ. R.,
ArffmannS.,
KragE.1987; Short-chain fatty acids and the irritable bowel syndrome: the effect of wheat bran. Scand J Gastroenterol 22:185–192 [View Article][PubMed]
MuellerS.,
SaunierK.,
HanischC.,
NorinE.,
AlmL.,
MidtvedtT.,
CresciA.,
SilviS.,
OrpianesiC. et al.2006; Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72:1027–1033 [View Article][PubMed]
MuyzerG.,
SmallaK.1998; Application of denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE) in microbial ecology. Antonie Van Leeuwenhoek 73:127–141 [View Article][PubMed]
NamY.-D.,
ChangH.-W.,
KimK.-H.,
RohS. W.,
KimM.-S.,
JungM.-J.,
LeeS.-W.,
KimJ.-Y.,
YoonJ.-H.,
BaeJ.-W.2008; Bacterial, archaeal, and eukaryal diversity in the intestines of Korean people. J Microbiol 46:491–501 [View Article][PubMed]
OhmanL.,
SimrénM.2007; New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis 39:201–215 [View Article][PubMed]
OttS. J.,
MusfeldtM.,
WenderothD. F.,
HampeJ.,
BrantO.,
FölschU. R.,
TimmisK. N.,
SchreiberS.2004; Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53:685–693 [View Article][PubMed]
PrydeS. E.,
DuncanS. H.,
HoldG. L.,
StewartC. S.,
FlintH. J.2002; The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 217:133–139 [View Article][PubMed]
QinJ.,
LiR.,
RaesJ.,
ArumugamM.,
BurgdorfK. S.,
ManichanhC.,
NielsenT.,
PonsN.,
LevenezF. et al.2010; A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59–65 [View Article][PubMed]
Rajilić-StojanovićM.,
SmidtH.,
De VosW. M.2007; Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol 9:2125–2136 [View Article][PubMed]
RinttiläT.,
KassinenA.,
MalinenE.,
KrogiusL.,
PalvaA.2004; Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 97:1166–1177 [View Article][PubMed]
SalonenA.,
De VosW. M.,
PalvaA.2010; Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 156:3205–3215 [View Article][PubMed]
ScanlanP. D.,
ShanahanF.,
O’MahonyC.,
MarchesiJ. R.2006; Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn’s disease. J Clin Microbiol 44:3980–3988 [View Article][PubMed]
ScherlingC.,
RoscherC.,
GiavaliscoP.,
SchulzeE. D.,
WeckwerthW.2010; Metabolomics unravel contrasting effects of biodiversity on the performance of individual plant species. PLoS ONE 5:e12569 [View Article][PubMed]
TanaC.,
UmesakiY.,
ImaokaA.,
HandaT.,
KanazawaM.,
FukudoS.2010; Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 22:512–519, e114–e115[PubMed]
VanhoutteT.,
HuysG.,
BrandtE.,
SwingsJ.2004; Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers. FEMS Microbiol Ecol 48:437–446 [View Article][PubMed]
WalterJ.,
HertelC.,
TannockG. W.,
LisC. M.,
MunroK.,
HammesW. P.2001; Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol 67:2578–2585 [View Article][PubMed]
WinterJ.,
PopoffM. R.,
GrimontP.,
BokkenheuserV. D.1991; Clostridium orbiscindens sp. nov., a human intestinal bacterium capable of cleaving the flavonoid C-ring. Int J Syst Bacteriol 41:355–357 [View Article][PubMed]
WoodmanseyE. J.,
McMurdoM. E.,
MacfarlaneG. T.,
MacfarlaneS.2004; Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 70:6113–6122 [View Article][PubMed]
ZwielehnerJ.,
LisztK.,
HandschurM.,
LasslC.,
LapinA.,
HaslbergerA. G.2009; Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly. Exp Gerontol 44:440–446 [View Article][PubMed]